Panacea Biotec Limited

NSE:PANACEABIO.NS

415.9 (INR) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 476.701,394.8-1,839.2370.5-2,394.1398.5-2,996.2427.3-5,882.8503.5-1,411.7861.2-1,357.9520.79-1,015.9375.3-897.5402.18-1,170294.2-234.8144.66
Short Term Investments 1,547.70403.63,678.41,468.74,788.22,020.55,992.42,616.911,765.65,012.782,823.4651.42,715.8467.552,031.8719.21,795149.882,340930.7469.68.22
Cash and Short Term Investments 2,024.41,798.41,798.41,839.21,839.22,394.12,4192,996.23,044.25,882.85,516.281,411.71,512.61,357.9988.341,015.91,094.5897.5552.061,1701,224.9234.8152.88
Net Receivables 0000768.40600.9201,221.70816.5601,219.50953.20942.10760.50858.30887.3
Inventory 1,668.201,779.401,999.202,020.901,945.302,127.2202,073.401,741.3701,526.401,476.9101,085.20814.27
Other Current Assets 1,345.10667.90745.40930.860533.201,445.4301,265.801,609.7301,044.804,149.4503,398.503,232.63
Total Current Assets 5,037.71,798.44,851.71,839.25,352.22,394.15,683.12,996.26,696.45,882.810,405.51,411.75,970.41,357.95,109.721,015.94,529.2897.56,832.681,1706,512234.85,078.86
Non-Current Assets:
Property, Plant & Equipment, Net 6,300.806,347.606,328.206,163.405,763.205,927.1906,153.806,278.9406,409.606,650.307,139.508,115
Goodwill 00000000000000000000000
Intangible Assets 350.503600302.70259.402340138.240148.20152.210170.10163.630165.50165.7
Goodwill and Intangible Assets 350.503600302.70259.402340138.240148.20152.210170.10163.630165.50165.7
Long Term Investments -1,514.901580-1,426.401.74050.70803.91026.10-410.770-642.70-88.1102.6056.26
Tax Assets 1,514.90-001,677.20110.960176.80301.7300.701.47015.8019.470146.40197.9
Other Non-Current Assets 2,256.7-1,798.4689.5-1,839.2487.7-2,394.1493-2,996.2588.3-5,882.8248.48-1,411.7177.9-1,357.9656.59-1,015.9906.3-897.5325-1,170366.6-234.8141.48
Total Non-Current Assets 7,393.1-1,798.47,555.1-1,839.27,369.4-2,394.17,028.5-2,996.26,813-5,882.87,419.55-1,411.76,506.7-1,357.96,678.44-1,015.96,859.1-897.57,070.29-1,1707,820.6-234.88,676.34
Total Assets 12,430.8012,406.8012,721.6012,711.6013,509.4017,825.05012,477.1011,788.16011,388.3013,903014,332.6013,755.2
Liabilities & Equity:
Current Liabilities:
Account Payables 1,699.901,536.801,746.401,773.2301,927.302,347.2203,515.602,466.5602,173.101,988.5202,019.802,697.1
Short Term Debt 0000-57300.550-584.100.520434.10844.4600093.75035.705,365.15
Tax Payables 0.501.302.405.600.800.9013.1013.104.5000000
Deferred Revenue 00775.130573.60591.60584.602,226.250485.4013.10001,229.4401,7510638.58
Other Current Liabilities 1,577.701,550.20995.301,538.9201,588.405,679.040698.60932.5102,374043.530208.1043.2
Total Current Liabilities 3,278.103,088.303,318.303,318.304,101.608,027.6805,632.204,256.6304,551.604,552.0804,014.609,382.61
Non-Current Liabilities:
Long Term Debt 215.70209.90-750201.640322.80341.0307,349.607,350.806,408.606,131.2806,545.20461.22
Deferred Revenue Non-Current 00-00281.20321.39000705.8800029.060003.8800039.69
Deferred Tax Liabilities Non-Current 1960225.50266.30203.7000-413.550002,439.500000000
Other Non-Current Liabilities 451.8-8,382.3500.80216.10265.4701,031.10542.3502,913058.1601,811.401,262.150931.20437.49
Total Non-Current Liabilities 863.5-8,382.3931.90969.80992.201,353.901,339.26010,262.609,848.4608,22007,393.4307,476.40898.71
Total Liabilities 4,141.6-8,382.34,020.204,288.104,310.505,455.509,366.94015,894.8014,105.09012,771.6011,945.51011,491010,281.32
Equity:
Preferred Stock 00216.54000216.54000216.54000216.54000217.9300096.39
Common Stock 61.3061.3061.3061.3061.3061.25061.3061.25061.3061.25061.3061.25
Retained Earnings 007,883.430007,898.520008,237.78000-2,540.08000-1,077.09000884.15
Accumulated Other Comprehensive Income/Loss 08,420.58,359.28,469.98,408.68,436.1795.018,081.28,019.98,488-730.51-3,388.4-3,449.7-2,286.9980.65-1,353.6-1,414.91,987.91,391.392,871.12,809.83,503.5-5,058.89
Other Total Stockholders Equity 8,267.8-38.2-8,099.97-36.40-35259.72-27.30-29.81,939.42-29.3-3,449.7-30-24.64-29.7-0-30.41,239.4-29.50-30.1919.4
Total Shareholders Equity 8,329.18,382.38,420.58,433.58,469.98,401.18,436.18,053.98,081.28,458.28,487.92-3,417.7-3,388.4-2,316.9-2,286.93-1,383.3-1,353.61,957.51,987.872,841.62,871.13,473.43,503.97
Total Equity 8,289.28,382.38,382.38,433.58,433.58,401.18,401.18,053.98,053.98,458.28,458.11-3,417.7-3,417.7-2,316.9-2,316.93-1,383.3-1,383.31,957.51,957.492,841.62,841.63,473.43,473.88
Total Liabilities & Shareholders Equity 12,430.8012,406.88,433.512,721.68,401.112,711.68,053.913,509.48,458.217,825.05-3,417.712,477.1-2,316.911,788.16-1,383.311,388.31,957.513,9032,841.614,332.63,473.413,755.2